Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NQO2 | P16083 | 1/20 | 0.36 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | BACE1 | P56817 | 1/20 | 0.34 |
| ▸ | CHKA | P35790 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 2/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18775291 | 0.85 | ALDH1A1 (0.43) | KDM4EALDH1A1RAB9ACHKA | |
| SCHEMBL20143116 | 0.83 | RXRA (0.41) | KDM4EALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL18775290 | 0.77 | KDM4E (0.56) | KDM4EALDH1A1RAB9ACHKAACHE | |
| SCHEMBL20143526 | 0.76 | RXRA (0.44) | KDM4EALDH1A1RAB9ACHKAACHE | |
| SCHEMBL18775289 | 0.71 | RAB9A (0.60) | KDM4EALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL7837346 | 0.70 | CHKA (0.49) | KDM4EALDH1A1RAB9AMAOBCHKA | |
| SCHEMBL367258 | 0.70 | ACHE (0.44) | ALDH1A1MEN1KMT2AMAOBTSHR | |
| SCHEMBL18775301 | 0.69 | KDM4E (0.45) | KDM4EALDH1A1RAB9ACHKAACHE | |
| SCHEMBL26463512 | 0.68 | MAOB (0.51) | MAOBACHE | |
| SCHEMBL11885 | 0.67 | ALDH1A1 (0.48) | KDM4EALDH1A1NQO2TSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2017-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | SCN11A, ECH1, H1-0 | KDM4E 1299/4885ALDH1A1 656/4885RAB9A 2408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.